A Phase II Trial of Oral Thalidomide as an Adjuvant Agent Following Metastasectomy in Patients With Recurrent Colorectal Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Thalidomide (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 28 Oct 2015 Biomarkers information updated
- 07 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2008 Status changed from completed to discontinued as reported by ClinicalTrials.gov.